Financial News · Live Terminal

Page 54 of 307

Goldman Sachs Upgrades Plains GP to Neutral From Sell, Adjusts Price Target to $24 From $18

Plains GP (PAGP) has an average rating of overweight and mean price target of $24, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Financial News · Live Terminal

Goldman Sachs Upgrades Plains GP to Neutral From Sell, Adjusts Price Target to $24 From $18

Goldman Sachs Upgrades Expro Group to Buy From Neutral, Price Target is $19

Evercore ISI Downgrades PVH to In Line From Outperform, Cuts Price Target to $79 From $95

UBS Downgrades EHang to Neutral From Buy, Cuts Price Target to $11.10 From $21

Citigroup Downgrades Ecopetrol to Neutral From Buy, Raise Price Target to $18 From $14

KeyBanc Upgrades Murphy Oil to Overweight From Sector Weight, Price Target is $48

Mizuho Initiates Century Therapeutics at Outperform

JPMorgan Upgrades Venture Global to Overweight From Neutral on Gas Volatility, Adjusts PT to $17 From $16

Bernstein Initiates TeraWulf at Outperform With $36 Price Target

RBC Downgrades ADC Therapeutics to Sector Perform From Outperform, Cuts Price Target to $2 From $6, Keeps Speculative Risk

Bernstein Initiates Cipher Mining at Outperform With $32 Price Target

Evercore ISI Initiates FedEx Freight Holding at Outperform With $168 Price Target

BofA Securities Upgrades UnitedHealth to Buy From Neutral, Price Target is $450

Benchmark Initiates CoStar Group at Buy With $45 Price Target

Wells Fargo Upgrades Oscar Health to Equalweight From Underweight, Adjusts PT to $20 From $11

Canaccord Genuity Initiates Pulse Biosciences at Buy With $32 Price Target

Gordon Haskett Downgrades Ollie's Bargain Outlet to Accumulate From Buy, Adjusts PT to $90 From $100

Wells Fargo Downgrades Commercial Metals to Equalweight From Overweight, Price Target is $77

Leerink Partners Initiates Absci at Outperform With $12 Price Target

Jefferies Upgrades RTX to Buy From Hold, Adjusts Price Target to $220 From $210

Goldman Sachs Upgrades Plains GP to Neutral From Sell, Adjusts Price Target to $24 From $18

Goldman Sachs Upgrades Expro Group to Buy From Neutral, Price Target is $19

Evercore ISI Downgrades PVH to In Line From Outperform, Cuts Price Target to $79 From $95

UBS Downgrades EHang to Neutral From Buy, Cuts Price Target to $11.10 From $21

Citigroup Downgrades Ecopetrol to Neutral From Buy, Raise Price Target to $18 From $14

KeyBanc Upgrades Murphy Oil to Overweight From Sector Weight, Price Target is $48

Mizuho Initiates Century Therapeutics at Outperform

JPMorgan Upgrades Venture Global to Overweight From Neutral on Gas Volatility, Adjusts PT to $17 From $16

Bernstein Initiates TeraWulf at Outperform With $36 Price Target

RBC Downgrades ADC Therapeutics to Sector Perform From Outperform, Cuts Price Target to $2 From $6, Keeps Speculative Risk

Bernstein Initiates Cipher Mining at Outperform With $32 Price Target

Evercore ISI Initiates FedEx Freight Holding at Outperform With $168 Price Target

BofA Securities Upgrades UnitedHealth to Buy From Neutral, Price Target is $450

Benchmark Initiates CoStar Group at Buy With $45 Price Target

Wells Fargo Upgrades Oscar Health to Equalweight From Underweight, Adjusts PT to $20 From $11

Canaccord Genuity Initiates Pulse Biosciences at Buy With $32 Price Target

Gordon Haskett Downgrades Ollie's Bargain Outlet to Accumulate From Buy, Adjusts PT to $90 From $100

Wells Fargo Downgrades Commercial Metals to Equalweight From Overweight, Price Target is $77

Leerink Partners Initiates Absci at Outperform With $12 Price Target

Jefferies Upgrades RTX to Buy From Hold, Adjusts Price Target to $220 From $210